Literature DB >> 18765817

HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.

Michael J Chao1, Martin C N M Barnardo, Matthew R Lincoln, Sreeram V Ramagopalan, Blanca M Herrera, David A Dyment, Alexandre Montpetit, A Dessa Sadovnick, Julian C Knight, George C Ebers.   

Abstract

The major locus for multiple sclerosis (MS) susceptibility is located within the class II region of the Major Histocompatibility Complex (MHC). HLA-DRB1 alleles, constituting the strongest MS susceptibility factors, have been widely exploited in research including construction of transgenic animal models of MS. Many studies have concluded that HLA-DRB1*15 allele itself determines MS-associated susceptibility. If this were true, haplotypes bearing this allele would confer equal risk. If HLA-DRB1*15 bearing haplotypes differed for risk, roles for other loci in this region would be implied and further study of the fine structure of this locus would be compelling. We have tested the hypothesis comparing haplotypes stratified by HLA class I tagging. We show here that HLA-DRB1*15-bearing-haplotypes in 1970 individuals from 494 MS families are indeed heterogeneous. Some HLA-DRB1*15 haplotypes determine susceptibility while others do not. Three groups of class I tagged HLA-DRB1*15 haplotypes were not over-transmitted: (i) HLA-DRB1*15-HLA-B*08 (TR = 25, NT = 23, Odds Ratio = 1.09), (ii) -HLA-B*27 (TR = 18, NT = 17, Odds Ratio = 1.06), and (iii) rare HLA-DRB1*15 haplotypes (frequency <0.02). Rare haplotypes were significantly different from common haplotypes, and transmissions were remarkably similar to those for class-I-matched non-HLA-DRB1*15 haplotypes. These results unambiguously indicate that HLA-DRB1*15 is part of a susceptibility haplotype but cannot be the susceptibility allele itself, requiring either epistatic interactions, epigenetic modifications on some haplotypes, or nearby structural variation. These findings strongly imply that differences among HLA-DRB1*15 haplotypes will furnish the basis for MHC-associated susceptibility in MS and raise the possibility that the MHC haplotype is the fundamental unit of genetic control of immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765817      PMCID: PMC2529028          DOI: 10.1073/pnas.0801042105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  A full genome search in multiple sclerosis.

Authors:  G C Ebers; K Kukay; D E Bulman; A D Sadovnick; G Rice; C Anderson; H Armstrong; K Cousin; R B Bell; W Hader; D W Paty; S Hashimoto; J Oger; P Duquette; S Warren; T Gray; P O'Connor; A Nath; A Auty; L Metz; G Francis; J E Paulseth; T J Murray; W Pryse-Phillips; R Nelson; M Freedman; D Brunet; J P Bouchard; D Hinds; N Risch
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 2.  Environmental factors and multiple sclerosis.

Authors:  George C Ebers
Journal:  Lancet Neurol       Date:  2008-03       Impact factor: 44.182

3.  The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer.

Authors:  A Spurkland; E G Celius; I Knutsen; A Beiske; E Thorsby; F Vartdal
Journal:  Tissue Antigens       Date:  1997-07

4.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).

Authors:  M Bunce; C M O'Neill; M C Barnardo; P Krausa; M J Browning; P J Morris; K I Welsh
Journal:  Tissue Antigens       Date:  1995-11

5.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis.

Authors:  J R O'Connell; D E Weeks
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

6.  Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group.

Authors:  A D Sadovnick; N J Risch; G C Ebers
Journal:  Can J Neurol Sci       Date:  1998-08       Impact factor: 2.104

7.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

8.  Genomewide scan of multiple sclerosis in Finnish multiplex families.

Authors:  S Kuokkanen; M Gschwend; J D Rioux; M J Daly; J D Terwilliger; P J Tienari; J Wikström; J Palo; L D Stein; T J Hudson; E S Lander; L Peltonen
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

9.  Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis.

Authors:  A Oturai; F Larsen; L P Ryder; H O Madsen; J Hillert; S Fredrikson; M Sandberg-Wollheim; M Laaksonen; N Koch-Henriksen; S Sawcer; L Fugger; P S Sorensen; A Svejgaard
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

10.  Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.

Authors:  J L Haines; H A Terwedow; K Burgess; M A Pericak-Vance; J B Rimmler; E R Martin; J R Oksenberg; R Lincoln; D Y Zhang; D R Banatao; N Gatto; D E Goodkin; S L Hauser
Journal:  Hum Mol Genet       Date:  1998-08       Impact factor: 6.150

View more
  27 in total

Review 1.  Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.

Authors:  David Luckey; Dikshya Bastakoty; Ashutosh K Mangalam
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

2.  Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.

Authors:  Alessandra Ferlini; Matteo Bovolenta; Marcella Neri; Francesca Gualandi; Alessandra Balboni; Anton Yuryev; Fabrizio Salvi; Donato Gemmati; Alberto Liboni; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

3.  MHC transmission: insights into gender bias in MS susceptibility.

Authors:  M J Chao; S V Ramagopalan; B M Herrera; S M Orton; L Handunnetthi; M R Lincoln; D A Dyment; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-01-05       Impact factor: 9.910

Review 4.  Genetics and pathogenesis of multiple sclerosis.

Authors:  R L Zuvich; J L McCauley; M A Pericak-Vance; J L Haines
Journal:  Semin Immunol       Date:  2009-09-22       Impact factor: 11.130

Review 5.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

Review 6.  The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

Authors:  Sandra M Cardona; Jenny A Garcia; Astrid E Cardona
Journal:  Methods Mol Biol       Date:  2013

7.  Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail.

Authors:  Erin E Longbrake; David A Hafler
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

8.  An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene.

Authors:  Sreeram V Ramagopalan; Roisin McMahon; David A Dyment; A Dessa Sadovnick; George C Ebers; Knut M Wittkowski
Journal:  BMC Med Genet       Date:  2009-02-04       Impact factor: 2.103

Review 9.  Is the risk of multiple sclerosis related to the 'biography' of the immune system?

Authors:  Bernd Krone; Frank Oeffner; John M Grange
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Multiple sclerosis: major histocompatibility complexity and antigen presentation.

Authors:  Sreeram V Ramagopalan; George C Ebers
Journal:  Genome Med       Date:  2009-11-06       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.